Evercore ISI Group analyst Liisa Bayko upgrades Akero Therapeutics (NASDAQ:AKRO) from In-Line to Outperform and raises the price target from $10 to $50.
Canadian Solar Inc (NASDAQ: CSIQ) has been performing exceptionally well in the first half of 2022 as the stock performance is up roughly 34% year-to-date.